341 related articles for article (PubMed ID: 24633157)
1. Recurrent PTPRB and PLCG1 mutations in angiosarcoma.
Behjati S; Tarpey PS; Sheldon H; Martincorena I; Van Loo P; Gundem G; Wedge DC; Ramakrishna M; Cooke SL; Pillay N; Vollan HKM; Papaemmanuil E; Koss H; Bunney TD; Hardy C; Joseph OR; Martin S; Mudie L; Butler A; Teague JW; Patil M; Steers G; Cao Y; Gumbs C; Ingram D; Lazar AJ; Little L; Mahadeshwar H; Protopopov A; Al Sannaa GA; Seth S; Song X; Tang J; Zhang J; Ravi V; Torres KE; Khatri B; Halai D; Roxanis I; Baumhoer D; Tirabosco R; Amary MF; Boshoff C; McDermott U; Katan M; Stratton MR; Futreal PA; Flanagan AM; Harris A; Campbell PJ
Nat Genet; 2014 Apr; 46(4):376-379. PubMed ID: 24633157
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis-related gene mutations drive a subset of angiosarcomas.
Cancer Discov; 2014 May; 4(5):OF18. PubMed ID: 24795022
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.
Prenen H; Smeets D; Mazzone M; Lambrechts D; Sagaert X; Sciot R; Debiec-Rychter M
Oncotarget; 2015 Nov; 6(34):36418-25. PubMed ID: 26474454
[TBL] [Abstract][Full Text] [Related]
4. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
[TBL] [Abstract][Full Text] [Related]
5. Molecular subtypes in canine hemangiosarcoma reveal similarities with human angiosarcoma.
Wang G; Wu M; Durham AC; Radaelli E; Mason NJ; Xu X; Roth DB
PLoS One; 2020; 15(3):e0229728. PubMed ID: 32210430
[TBL] [Abstract][Full Text] [Related]
6. A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells.
Kunze K; Spieker T; Gamerdinger U; Nau K; Berger J; Dreyer T; Sindermann JR; Hoffmeier A; Gattenlöhner S; Bräuninger A
Cancer Res; 2014 Nov; 74(21):6173-83. PubMed ID: 25252913
[TBL] [Abstract][Full Text] [Related]
7. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.
Calvete O; Garcia-Pavia P; Domínguez F; Mosteiro L; Pérez-Cabornero L; Cantalapiedra D; Zorio E; Ramón Y Cajal T; Crespo-Leiro MG; Teulé Á; Lázaro C; Morente MM; Urioste M; Benitez J
J Am Heart Assoc; 2019 Sep; 8(18):e012875. PubMed ID: 31510873
[TBL] [Abstract][Full Text] [Related]
8. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
[TBL] [Abstract][Full Text] [Related]
9. Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway.
Murali R; Chandramohan R; Möller I; Scholz SL; Berger M; Huberman K; Viale A; Pirun M; Socci ND; Bouvier N; Bauer S; Artl M; Schilling B; Schimming T; Sucker A; Schwindenhammer B; Grabellus F; Speicher MR; Schaller J; Hillen U; Schadendorf D; Mentzel T; Cheng DT; Wiesner T; Griewank KG
Oncotarget; 2015 Nov; 6(34):36041-52. PubMed ID: 26440310
[TBL] [Abstract][Full Text] [Related]
10. Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis.
Beca F; Krings G; Chen YY; Hosfield EM; Vohra P; Sibley RK; Troxell ML; West RB; Allison KH; Bean GR
Mod Pathol; 2020 Aug; 33(8):1518-1526. PubMed ID: 32123305
[TBL] [Abstract][Full Text] [Related]
11. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.
Painter CA; Jain E; Tomson BN; Dunphy M; Stoddard RE; Thomas BS; Damon AL; Shah S; Kim D; Gómez Tejeda Zañudo J; Hornick JL; Chen YL; Merriam P; Raut CP; Demetri GD; Van Tine BA; Lander ES; Golub TR; Wagle N
Nat Med; 2020 Feb; 26(2):181-187. PubMed ID: 32042194
[TBL] [Abstract][Full Text] [Related]
12. Vascular-targeted agents for the treatment of angiosarcoma.
Young RJ; Woll PJ; Staton CA; Reed MW; Brown NJ
Cancer Chemother Pharmacol; 2014 Feb; 73(2):259-70. PubMed ID: 24253175
[TBL] [Abstract][Full Text] [Related]
13. Somatic mutation signatures in primary liver tumors of workers exposed to ionizing radiation.
Goerlitz DS; Blancato J; Ramesh A; Islam M; Graham GT; Revina V; Kallakury B; Zeck J; Kirillova E; Loffredo CA
Sci Rep; 2019 Dec; 9(1):18199. PubMed ID: 31796844
[TBL] [Abstract][Full Text] [Related]
14. Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies.
Zhrebker L; Cherni I; Gross LM; Hinshelwood MM; Reese M; Aldrich J; Guileyardo JM; Roberts WC; Craig D; Von Hoff DD; Mennel RG; Carpten JD
BMC Cancer; 2017 Jan; 17(1):17. PubMed ID: 28056866
[TBL] [Abstract][Full Text] [Related]
15. Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report.
Teruyama F; Kuno A; Murata Y; Nakagawa T; Shiba-Ishii A; Yuguchi S; Noguchi M
Pathol Int; 2022 Sep; 72(9):457-463. PubMed ID: 35801418
[TBL] [Abstract][Full Text] [Related]
16. Protein Tyrosine Phosphatase, Receptor Type B (PTPRB) Inhibits Brown Adipocyte Differentiation through Regulation of VEGFR2 Phosphorylation.
Kim JS; Kim WK; Oh KJ; Lee EW; Han BS; Lee SC; Bae KH
J Microbiol Biotechnol; 2019 Apr; 29(4):645-650. PubMed ID: 30845793
[TBL] [Abstract][Full Text] [Related]
17. Angiosarcoma heterogeneity and potential therapeutic vulnerability to immune checkpoint blockade: insights from genomic sequencing.
Boichard A; Wagner MJ; Kurzrock R
Genome Med; 2020 Jul; 12(1):61. PubMed ID: 32646514
[TBL] [Abstract][Full Text] [Related]
18. New molecular targets in canine hemangiosarcoma-Comparative review and future of the precision medicine.
Kapturska KM; Pawlak A
Vet Comp Oncol; 2023 Sep; 21(3):357-377. PubMed ID: 37308243
[TBL] [Abstract][Full Text] [Related]
19. The receptor protein tyrosine phosphatase PTPRB negatively regulates FGF2-dependent branching morphogenesis.
Soady KJ; Tornillo G; Kendrick H; Meniel V; Olijnyk-Dallis D; Morris JS; Stein T; Gusterson BA; Isacke CM; Smalley MJ
Development; 2017 Oct; 144(20):3777-3788. PubMed ID: 28870991
[TBL] [Abstract][Full Text] [Related]
20. A genetic screen for vascular mutants in zebrafish reveals dynamic roles for Vegf/Plcg1 signaling during artery development.
Covassin LD; Siekmann AF; Kacergis MC; Laver E; Moore JC; Villefranc JA; Weinstein BM; Lawson ND
Dev Biol; 2009 May; 329(2):212-26. PubMed ID: 19269286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
